activins has been researched along with Bone Loss, Perimenopausal in 3 studies
Activins: Activins are produced in the pituitary, gonads, and other tissues. By acting locally, they stimulate pituitary FSH secretion and have diverse effects on cell differentiation and embryonic development. Activins are glycoproteins that are hetero- or homodimers of INHIBIN-BETA SUBUNITS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Anastasilakis, AD | 3 |
| Polyzos, SA | 3 |
| Rodopaios, NE | 1 |
| Makras, P | 3 |
| Kumar, A | 2 |
| Kalra, B | 2 |
| Mantzoros, CS | 2 |
| Savvidis, M | 1 |
| Anastasilakis, DA | 1 |
| Sarridimitriou, A | 1 |
| Gkiomisi, A | 1 |
| Savvides, M | 1 |
| Papatheodorou, A | 1 |
| Terpos, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Role of Myokines in Postmenopausal Osteoporosis[NCT04206618] | 220 participants (Actual) | Observational | 2019-06-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for activins and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study.
Topics: Activins; Case-Control Studies; Female; Follistatin; Follistatin-Related Proteins; Glycoproteins; Hu | 2023 |
Association of activins, follistatins and inhibins with incident hip fracture in women with postmenopausal osteoporosis: a proof of concept, case-control study.
Topics: Activins; Case-Control Studies; Female; Follistatin; Glycoproteins; Humans; Inhibins; Osteoporosis, | 2023 |
Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment.
Topics: Activins; Age Factors; Aged; Aging; Biomarkers; Bone Density; Bone Density Conservation Agents; Case | 2013 |